Author

Jasmina Zanoncello

Josep Carreras Leukaemia Research Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Ana Angulo‐UrarteiD· 1 shared Carlota RoviraiD· 1 shared Cinzia Emilia LavarinoiD· 1 shared Eulàlia BaselgaiD· 1 shared Helena SabataiD· 1 shared Jaume MoraiD· 1 shared Laia MuixíiD· 1 shared Mariona GrauperaiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Ana Angulo‐UrarteORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Low dose AKT inhibitor miransertib cures PI3K-related vascular malformations in preclinical models of human disease

Piotr Kobialka, Helena Sabata, Odena Vilalta, Ana Angulo‐Urarte, Laia Muixí, Jasmina Zanoncello, Oscar Muñoz‐Aznar, Nagore Gené Olaciregui, Cinzia Emilia Lavarino, Verónica Celis, Carlota Rovira, Susana López Fernández, Eulàlia Baselga, Jaume Mora, Sandra D. Castillo, Mariona Graupera

The paper develops a preclinical model of PI3K-driven vascular malformations and shows that low-dose AKT inhibitor miransertib prevents and regresses these malformations in mice and human endothelial cells.

bioRxiv · Jul 16, 2021 · PreprintMolecular Biology